The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice
Abstract
As a novel risk gene for Alzheimer's disease (AD), triggering receptor expressed on myeloid cells 2 (TREM2) gene encodes a type I transmembrane receptor that is uniquely expressed by the microglia in the brain. Emerging evidence indicates a strong association between TREM2 and tau pathology in the cerebral spinal fluid or brain tissue of AD patients. In line with these clinical findings, we found that TREM2 was upregulated in the brain of P301S mice, an animal model of tau pathology, during disease progression. However, despite this information, the precise role of TREM2 in tau pathology remains largely unknown. In our recent studies, we revealed that silencing microglial TREM2 expression in P301S mice exacerbated spatial cognitive deficits and tau pathology. Based on this evidence, we hypothesized that TREM2 might exert a protective effect in tau-related neurodegenerative diseases. In the present study, to test this hypothesis, a lentiviral-mediated strategy was employed to selectively overexpress TREM2 on microglia in the brain of P301S mice. For the first time, we showed that TREM2 overexpression rescued spatial cognitive impairments and ameliorated neuropathologies including neuronal and synaptic loss as well as tau hyperphosphorylation. Meanwhile, this protective effect was likely attributed to the suppression of neuroinflammation and subsequent attenuation of tau kinase activity, since the expression of pro-inflammatory cytokines including Tnf, Il1b and Il6 as well as the activity of tau kinase including glycogen synthase kinase 3β and cyclin-dependent kinase 5 was significantly reduced following TREM2 overexpression. Additionally, the suppressed neuroinflammation might be ascribed to the M2 activation of microglia induced by TREM2, as the expression of M2 phenotype makers including Arg1, Retnla, Il4 and Il10 was markedly increased. Taken together, these findings support the concept of TREM2 as a valuable target against AD as well as other tau-related neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“overexpressing murine TREM2 in microglia is found to reduce tau hyperphosphorylation in the mid-disease stage in P301S mice68.”
From Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight (2018) · cites this paper as [68]
Citations
Cites
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798
TREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701
Alternatively activated microglia and macrophages in the central nervous system
Franco, R., & Fernández‐Suárez, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.003 · Cited by 674
TREM2 sustains microglial expansion during aging and response to demyelination
Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77983 · Cited by 525
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–176 of 176
Ahmed, S., Ma, N., Kawanokuchi, J., Matsuoka, K., Oikawa, S., Kobayashi, H., Hiraku, Y., & Murata, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-57973-4 · Cited by 28
TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis
Ming, S., Li, X., Xiao, Q., Qu, S., Wang, Q., Fang, Q., Liang, P., Xu, Y., Yang, J., Yang, Y., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci159400 · Cited by 26
RetractedSanjay, S., Park, M., & Lee, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137300 · Cited by 28
Zhang, X., Yan, F., Cui, J., Wu, Y., Luan, H., Yin, M., Zhao, Z., Feng, J., & Zhang, J. (2017) · Mediators of Inflammation · doi:10.1155/2017/9340610 · Cited by 27
Association study of serum soluble TREM2 with vascular dementia in Chinese Han population
Wang, Q., Xu, Y., Qi, C., Liu, A., & Zhao, Y. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1702548 · Cited by 26
Sharma, A., Sanjay, S., Jaiswal, V., Park, M., & Lee, H. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213363 · Cited by 28
Luo, L., Chen, J., Wu, Q., Yuan, B., Hu, C., Yang, T., Wei, H., & Li, T. (2023) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2023.104090 · Cited by 24
Lin, C., Kong, Y., Chen, Q., Zeng, J., Pan, X., & Miao, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1420731 · Cited by 24
Self-citationElbadawy, N. N., Saad, M. A., Elfarrash, S., Ahmed, M. A. E., & Abdelkader, N. F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177305 · Cited by 24
Zhang, X., Chen, X., Zhang, L., Sun, Y., Liang, Y., Li, H., & Zhang, Y. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105639 · Cited by 23
Self-citationTau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
Koller, E. J., & Chakrabarty, P. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00151 · Cited by 23
Zhao, Y., Guo, Q., Tian, J., Liu, W., & Wang, X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102596 · Cited by 23
Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer’s Disease
Xie, J., Wang, H., Lin, T., & Bi, B. (2017) · BioMed Research International · doi:10.1155/2017/2986460 · Cited by 22
Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice
Hui, C. W., Song, X., Ma, F., Shen, X., & Herrup, K. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1338-7 · Cited by 22
Wang, R., Zhou, Z., Wang, D., Zhao, Q., Zhang, C., Liu, C., Zhao, H., Yuan, C., Yuan, D., & Wang, T. (2021) · Food & Function · doi:10.1039/d0fo02946g · Cited by 22
Transgenic Mouse Models for the Study of Neurodegenerative Diseases
Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 21
van Rees, G. F., Lago, S. G., Cox, D., Tomasik, J., Rustogi, N., Weigelt, K., Özcan, S., Cooper, J. D., Drexhage, H. A., Leweke, F. M., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.003 · Cited by 22
GSK3-Driven Modulation of Inflammation and Tissue Integrity in the Animal Model
Kühl, F., Brand, K., Lichtinghagen, R., & Huber, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158263 · Cited by 22
Jiang, T., Zhang, Y., Fu, X., Duan, R., Wang, S., Zhang, Q.-Q., Wei, B., Huang, T., Gong, P., & Yan, E. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343888 · Cited by 19
Self-citationReduction in GABAB on glia induce Alzheimer’s disease related changes
Osse, A. M. L., Pandey, R. S., Wirt, R. A., Ortiz, A. A., Salazar, A., Kimmich, M. J., Strom, E. N. T., Oblak, A. L., Lamb, B. T., Hyman, J. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.002 · Cited by 21
The innate immune response in tauopathies
Johnson, A. M., & Lukens, J. R. (2023) · European Journal of Immunology · doi:10.1002/eji.202250266 · Cited by 22
Tauopathies: Mechanisms and Therapeutic Strategies
Tan, C., Zhang, X.-Y., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170187 · Cited by 21
Self-citationPeng, L., Liu, S., Xu, J., Xie, W., Fang, X., Xia, T., & Gu, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108903 · Cited by 21
TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Li, L., Zheng, X., Ma, H., Zhu, M., Li, X., Sun, X., & Feng, X. (2025) · Cells · doi:10.3390/cells14171387 · Cited by 22
Nordengen, K., Kirsebom, B., Richter, G., Pålhaugen, L., Gísladóttir, B., Siafarikas, N., Nakling, A. E., Rongve, A., Bråthen, G., Grøntvedt, G. R., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02973-w · Cited by 21
Immune Response at the Crossroads of Atherosclerosis and Alzheimer's Disease
Stahr, N. A., & Galkina, E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870144 · Cited by 18
The Role of TREML2 in Alzheimer’s Disease
Wang, S., Gong, P., Yan, E., Zhang, Y., & Jiang, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200406 · Cited by 18
Self-citationImmunological aspects of central neurodegeneration
Niso‐Santano, M., Fuentes, J. M., & Galluzzi, L. (2024) · Cell Discovery · doi:10.1038/s41421-024-00666-z · Cited by 17
Toomey, C. E., Heywood, W., Benson, B. C., Packham, G., Mills, K. A., & Lashley, T. (2020) · Brain Pathology · doi:10.1111/bpa.12842 · Cited by 17
Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion
Wang, Q., Xiao, X., Yang, Y., Gong, P., Jiang, T., & Zhang, Y.-D. (2018) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320318799587 · Cited by 16
Self-citationApoE4 makes microglia trem2bling
Heneka, M. T. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.032 · Cited by 15
Zhu, X., Ma, T., Liu, L., & Dai, W.-Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.332160 · Cited by 16
Self-citationDehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation
Li, L., Xu, N., He, Y., Tang, M., Yang, B., Du, J., Liang, C., Mao, X., Song, B., Zhou, H., et al. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00479 · Cited by 14
The role of peripheral innate immune cells in Alzheimer’s disease progression
Cao, Y., Tang, K., Ma, P., Zhang, R., Yang, Y., Li, T., Zhang, Y., & Peng, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1616939 · Cited by 15
Self-citationApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
Lennol, M. P., Bordier, C., Kamelher, L., Ulrich, J. D., Holtzman, D. M., & Gratuze, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250965 · Cited by 14
The role of frontotemporal dementia associated genes in patients with Alzheimer's disease
Xiao, X., Yuan, Z., Guo, L., Liao, X., Zhou, Y., Zhang, W., Zhou, L., Wang, X., Liu, X., Liu, H., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.016 · Cited by 13
Xu, Y., Jiang, H., Zhu, B., Cao, M., Feng, T., Sun, Z., Du, G., & Zhao, Z. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14238 · Cited by 11
Alves, R. L., Gonçalves, A., Voytyuk, I., & Harrison, D. C. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115234 · Cited by 11
MFN2 ameliorates cell apoptosis in a cellular model of Parkinson's disease induced by rotenone
Yang, Y., Xue, L., Xue, X., Ou, Z., Jiang, T., & Zhang, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6595 · Cited by 12
Self-citationPeng, X., Yang, Z.-K., Guo, H., Wu, X., Ruganzu, J. B., Liu, Z.-Z., Wu, S.-D., & Yang, W.-N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05449-5 · Cited by 11
Shallie, O. F., & Mabandla, M. V. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112795 · Cited by 12
Tau immunotherapy in Alzheimer’s disease and progressive supranuclear palsy
Karimi, N., Catak, F. B., Arslan, E. O., Saghazadeh, A., & Rezaei, N. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109445 · Cited by 11
Katsumoto, A., Kokiko‐Cochran, O. N., Bemiller, S. M., Xu, G., Ransohoff, R. M., & Lamb, B. T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978423 · Cited by 11
Kreiner, G. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.09.006 · Cited by 9
Supporting microglial niches for therapeutic benefit in psychiatric disorders
Churchward, M. A., Michaud, E., & Todd, K. G. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109648 · Cited by 9
A systematic review of the role of TREM2 in Alzheimer’s disease
Yin, Y., Yang, H.-C., Li, R., Wu, G., Qin, Q., & Tang, Y. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003000 · Cited by 8
Jang, B.-K., Shin, S. J., Park, H. H., Kumar, V., Park, Y., Kim, J. Y., Kang, H., Park, S. Y., Kwon, Y., Shin, S.-E., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics17010013 · Cited by 7
Tian, M.-L., Ni, X.-N., Li, J., Tan, C., Cao, X., Tan, L., & Initiative, A. D. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00742 · Cited by 6
Self-citationNi, J.-W., Li, C., Chen, X., & Cai, W. (2022) · Neurology India · doi:10.4103/0028-3886.364080 · Cited by 8
Singh, A. S., Naqvi, A. R., & Chanu, M. T. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.01.050 · Cited by 7
Zhang, L., Peng, C., Chu, Y.-Q., Zhou, Z.-M., Hua, R., & Zhang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1412699 · Cited by 8
Self-citationThe engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease
Palova, D., Csokova, N. T., Markova, K., Kontseková, E., Kováčech, B., & Žilková, M. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021029 · Cited by 6
Paul, D., & Basavan, D. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00446-0 · Cited by 5
Ameliorative role of Teucrium polium extract on γ-radiation toxicity in brain of albino rats
Saif‐Elnasr, M., Fattah, S. M. A., & Mohamed, T. A. (2019) · Egyptian Journal of Radiation Sciences and Applications · doi:10.21608/ejrsa.2019.9867.1065 · Cited by 5
Fu, X., Chen, S., Lian, H.-W., Deng, Y., Duan, R., Zhang, Y., & Jiang, T. (2023) · Brain Sciences · doi:10.3390/brainsci13040642 · Cited by 5
Self-citationWang, Y., Huang, L., Guo, H., Liu, M., Zhang, Y., Zhang, Z., Hao, Q., Tan, C., & Tan, L. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16273 · Cited by 4
Self-citationÇELİK, H., Dalkılınç, E., Aydın, Ş., Çelik, O., Küçükler, S., Topal, A., Akay, R., Gönüllü, S., Yıldız, M. O., Alım, B., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05889-7 · Cited by 2
Inflammatory CD11c+ B Cells Induced by the TREM2 Signal Accelerate Sepsis Development
Ming, S., Chen, Z., Yang, J., Liu, J., Liu, X., Yang, L., Tan, Z., Zhou, H., Wu, Y., & Huang, X. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf112 · Cited by 1
Song, M., Liu, R., Zhang, L., Liu, C., Song, F., & Zhao, X. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117551 · Cited by 1
The role of Annexin A2 in Alzheimer's disease: From cellular functions to therapeutic potential
Shu, D., Fu, C., Liu, Z., & Li, C. (2026) · FEBS Journal · doi:10.1111/febs.70574 · Cited by 1
Autophagy and Proteostasis: A Unifying Theory of Neurodegenerative Disease
Novack, J. P. (2017) · Journal of Restorative Medicine · doi:10.14200/jrm.2017.6.0102 · Cited by 1
Achouri-Rassas, A., Fray, S., Saied, Z., Sassi, S. B., Ali, N., & Baraket, G. (2025) · Neurological Research · doi:10.1080/01616412.2025.2472841 · Cited by 1
(−)‐Epicatechin Rescues Memory Deficits by Activation of Autophagy in a Mouse Model of Tauopathies
Wu, Y., Li, T., Jiang, X., Ling, J., Zhao, Z., Zhu, J., Chen, C., Liu, Q., Yang, X., Shen, X., et al. (2025) · MedComm · doi:10.1002/mco2.70144 · Cited by 2
Carbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Hodgkinson, A., Dobson, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.16.452732 · Cited by 1
Does Irisin Link Physical Exercise with Alzheimer’s Disease?Preprint
Sumsuzzman, D. M., Jin, Y., & Hong, Y. (2017) · Preprints.org · doi:10.20944/preprints201712.0023.v1
Fernandez, F., & Andrews, J. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00009-4
Jadhav, V. (2021) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2086
TREM2 limits progression of deficits and spreading of tau pathology in micePreprint
Feiten, A., Au, C. G., Sabale, M., van Hummel, A., van der Hoven, J., Deng, Y., Przybyla, M., Bright, F., Butler, T., Delerue, F., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-741896/v2
Franzmeier, N., Suárez‐Calvet, M., Frontzkowski, L. K., Moore, A. M., Hohman, T. J., Morenas‐Rodríguez, E., Nuscher, B., Shaw, L. M. J., Trojanowski, J. Q., Dichgans, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13071124
Nordengen, K., Kirsebom, B.-E., Richter, G., Pålhaugen, L., Gísladóttir, B., Siafarikas, N., Nakling, A. E., Rongve, A., Bråthen, G., Grøntvedt, G. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26653528
Nordengen, K., Kirsebom, B.-E., Richter, G., Pålhaugen, L., Gísladóttir, B., Siafarikas, N., Nakling, A. E., Rongve, A., Bråthen, G., Grøntvedt, G. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26653531
Nordengen, K., Kirsebom, B.-E., Richter, G., Pålhaugen, L., Gísladóttir, B., Siafarikas, N., Nakling, A. E., Rongve, A., Bråthen, G., Grøntvedt, G. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26653534
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Role of T-cell immunity in the pathophysiology of Alzheimer’s disease and other Tauopathies
Matta, K. (2024) · theses.fr (ABES) · doi:10.70675/cea4fe5ez67c3z4445z92f7z39af62ba059b
Targeting Microglial Receptors for Alzheimer’s Disease: Translational Barriers from Bench to Bedside
Tang, X., Hasan, I., & Xu, J. (2026) · Neuropharmacology and Therapy · doi:10.15212/npt-2026-0008
Metadata
- Authors
- Jiang, T., Zhang, Y.-D., Chen, Q., Gao, Q., Zhu, X.-C., Zhou, J.-S., Shi, J.-Q., Lu, H., Tan, L., & Yu, J.-T.
- Affiliations
- University of California, San Francisco (US)
- Nanjing Medical University (CN)
- Nanjing First Hospital (CN)
- Qingdao Municipal Hospital (CN)
- Qingdao University (CN)
- Corresponding author
- Tan, Lan
- Yu, Jin-Tai
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 105
- Pages
- 196-206
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2246389678
- Cited by
- 176
- References
- 40
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 21 · 2023: 20 · 2022: 17 · 2021: 20 · 2020: 19 · 2019: 21 · 2018: 18 · 2017: 18 · 2016: 5
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81501092, 81471309, 81571245, 81500916)
- Natural Science Foundation of Jiangsu Province (BK20150091, BK20151084)
- China Postdoctoral Science Foundation (2015M580448)
- Qingdao Key Health Discipline Development Fund
- Qingdao Outstanding Health Professional Development Fund
- Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- TREM2, microglia, P301S tau transgenic mice, tau pathology, Alzheimer's disease, neuroprotection, neuroinflammation, tau hyperphosphorylation, glycogen synthase kinase-3β, cyclin-dependent kinase 5, inflammatory cytokines, lentiviral overexpression
- MeSH terms
- Neuroprotection, Glycogen Synthase Kinase 3 beta, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Encephalitis, Exploratory Behavior, Genetic Vectors, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Transgenic, Phenotype, Phosphorylation, Receptors, Immunologic, Lentivirus, tau Proteins, Microglia, Maze Learning, Inflammation Mediators, Cyclin-Dependent Kinase 5, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
